Ross H. Lowe

发表

Concentrations of Methadone in Breast Milk and Plasma in the Immediate Perinatal Period

M. Huestis, J. Schroeder, R. Choo, 2007, Journal of human lactation : official journal of International Lactation Consultant Association.

Validation of a two-dimensional gas chromatography mass spectrometry method for the simultaneous quantification of cannabidiol, Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in plasma

M. Huestis, K. Scheidweiler, Allan J. Barnes, 2010, Analytical and bioanalytical chemistry.

Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?

R. Herning, J. Cadet, M. Huestis, 2009, Addiction.

CLINICAL STUDY: Postmortem diagnosis and toxicological validation of illicit substance use

J. Kleinman, J. Cadet, W. Freed, 2008, Addiction biology.

Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.

R. Herning, J. Cadet, M. Huestis, 2009, Journal of analytical toxicology.

Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure.

R. Herning, J. Cadet, M. Huestis, 2009, Drug and alcohol dependence.

Methadone maintenance and long-term lactation.

M. Huestis, R. Choo, L. Jansson, 2008, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.

Simultaneous quantification of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry.

M. Huestis, Allan J. Barnes, Ross H. Lowe, 2007, Journal of chromatography. A.

Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC.

D. Kelly, M. Huestis, D. Gorelick, 2009, Clinical chemistry.

Transcriptional Changes Common to Human Cocaine, Cannabis and Phencyclidine Abuse

J. Kleinman, K. Becker, W. Freed, 2006, PloS one.

Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry.

M. Huestis, Allan J. Barnes, G. Milman, 2010, Journal of chromatography. A.

Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans.

Marilyn A Huestis, M. Huestis, D. Gorelick, 2009, Journal of analytical toxicology.

A validated positive chemical ionization GC/MS method for the identification and quantification of amphetamine, opiates, cocaine, and metabolites in human postmortem brain.

J. Kleinman, W. Freed, T. Hyde, 2006, Journal of mass spectrometry : JMS.

Two-dimensional gas chromatography/electron-impact mass spectrometry with cryofocusing for simultaneous quantification of MDMA, MDA, HMMA, HMA, and MDEA in human plasma.

M. Huestis, Erin A Kolbrich, Ross H. Lowe, 2008, Clinical chemistry.

Simultaneous GC–EI-MS Determination of Δ9-Tetrahydrocannabinol, 11-Hydroxy-Δ9-Tetrahydrocannabinol, and 11-nor-9-Carboxy-Δ9-Tetrahydrocannabinol in Human Urine Following Tandem Enzyme-Alkaline Hydrolysis

M. Huestis, S. Pirnay, Ross H. Lowe, 2007 .

Intra- and intersubject whole blood/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusing.

R. Herning, J. Cadet, M. Huestis, 2009, Clinical chemistry.

A Mechanism for the Inhibition of Neural Progenitor Cell Proliferation by Cocaine

H. M. Geller, K. Becker, W. Freed, 2008, PLoS medicine.

Postmortem diagnosis and toxicological validation of illicit substance use.

M. Huestis, E. Lehrmann, A. Deep-Soboslay, 2008, Addiction biology.

Selection and optimization of hydrolysis conditions for the quantification of urinary metabolites of MDMA.

M. Huestis, S. Pirnay, Ross H. Lowe, 2006, Journal of analytical toxicology.